Project Oncology® CME presents a wide array of oncology CME topics designed to educate and enlighten practitioners on late-breaking discoveries, novel treatment options, evolving methods of patient management, and more. The series provides cutting-edge updates on cancer biology, diagnosis, and multidisciplinary management, as well as evidence-based recommendations to achieve optimal patient outcomes. Each program is designed to be a short, easy-to-digest format of 15 to 30 minutes.
Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer
Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC
Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC
Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease
Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease
Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities
Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma
Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC
Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC
The Role of HER3 Expression in Advanced Solid Tumors
The Role of HER3 Expression in Advanced Solid Tumors
Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC
Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
RCC Treatment Strategies in a Favorable-Risk Patient
RCC Treatment Strategies in a Favorable-Risk Patient
RCC Treatment Strategies in a Poor-Risk Patient
RCC Treatment Strategies in a Poor-Risk Patient
The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy
The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy
Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping
Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping